-

12:31:24 PM

SIEN Stock News

SIEN - Sientra Inc

08/10/23 4:03 PM

Nasdaq : SIEN

earningslow float

Sientra Reports Record Second Quarter Financial and Operational Results

Revenue growth of 7.5% driven by continued market share gains in reconstruction and augmentation Best operational results in company history with 95% and 63% year-over-year improvement in operating cash flow and adjusted EBITDA respectively Continued success in advancing products through the FDA

RHEA-AI

neutral

07/27/23 4:05 AM

Nasdaq : SIEN

conferencesearningslow float

Sientra to Report Second Quarter 2023 Financial Results on August 10, 2023

Sientra, Inc. (NASDAQ: SIEN)(“Sientra” or the “Company”), a medical aesthetics company developing the safest and most innovative solutions for the best aesthetic outcomes, today announced that it will release financial results for the second

RHEA-AI

neutral

06/30/23 4:42 PM

Nasdaq : SIEN

low float

Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Sientra, Inc. (NASDAQ:SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced that on June 27, 2023, the Company approved equity award grants under the Sientra Inc. Inducement Plan to

RHEA-AI

very positive

06/20/23 8:35 AM

Nasdaq : SIEN

managementlow float

Sientra Announces Appointment of Alexander W. Casdin to Board of Directors

Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, announced the appointment of Alexander W. Casdin to the Company’s Board of Directors,

RHEA-AI

very positive

06/08/23 4:05 PM

Nasdaq : SIEN

low float

Sientra Announces FDA-Clearance of Next Generation AlloX2 Pro™ Tissue Expander

Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical

RHEA-AI

positive

05/17/23 8:30 AM

Nasdaq : SIEN

low float

Sientra Announces FDA-Clearance of Novel Portfinder™ Technology

Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, announced

RHEA-AI

positive

05/11/23 4:02 PM

Nasdaq : SIEN

earningslow float

Sientra Reports Record First Quarter 2023 Operational Results

Eleventh consecutive quarter of year-over-year growth, fueled by market outperformance in reconstruction Continued improvement in non-GAAP OPEX, adjusted EBITDA, and free cash flow performance demonstrating clear pathway to profitability Doubled

RHEA-AI

neutral

05/01/23 4:05 PM

Nasdaq : SIEN

conferencesearningslow float

Sientra to Report First Quarter 2023 Financial Results on May 11, 2023

Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced that it will release financial results for the first quarter of 2023 after

RHEA-AI

neutral

03/30/23 4:02 PM

Nasdaq : SIEN

low float

Sientra Reports Record Fourth Quarter and Full Year Revenues and Expands Total Addressable Market With New Product Launches

Continued 2+ year trend of consecutive record quarterly growth; fastest growing brand in the US breast market Disciplined cash management and enhanced operating leverage for 40% improvement in free cash flow results Significantly increased total addressable market with the launch of Viality™, a

RHEA-AI

neutral

03/20/23 8:35 AM

Nasdaq : SIEN

conferencesearningslow float

Sientra to Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023

Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced that it will release financial results for the fourth quarter and full

RHEA-AI

neutral

1 2 3 4 5 6 7 8 Next